Tag: Alzheimer’s risk factors
Uncovering the Reality of Novel Alzheimer’s Medications
In early July, the US Food and Drug Administration (FDA) approved a new treatment called donanemab for individuals with early-stage Alzheimer’s disease. This medication is the second drug that has been proven to slow...